And this year, the discounts on shoes at after-Christmas sales are oh-so-sweet. The Zappos Winter Clearance sale is full of fantastic deals on top brands. Whether you got every pair of shoes on ...

Zappos has a huge Boxing Day sale going on, and we’ve rounded up some of their most popular comfy footwear that’s still in stock — for now. Check out some of the best on-sale styles, and act quick ...

According to the report, Musk has been violating the rules set out by his "top secret" security clearance for years. Musk was even denied high-level security access by the Air Force, according to ...

Now, Shoe Zone, which has 297 stores across the country, have become the first business to announce closures as a direct result of the budget. A company spokesperson said: ‘These additional ...

Teva Pharmaceuticals’TEVA0.63%increase; green up pointing triangle shares soared and Sanofi’sSAN-0.33%decrease; red down pointing triangle stock moved higher following positive results from ...

The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those taking placebo treatment. Teva announced it was partnering with Sanofi to ...

On Tuesday, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis (UC ...

ADRs of Teva Pharmaceutical (NYSE:TEVA) and Sanofi (NASDAQ:SNY) traded higher in the premarket on Tuesday after the companies said that their experimental antibody therapy, duvakitug, reached the ...

Merck is working on the monoclonal antibody MK-7240—formerly known as PRA023—which it acquired in its $10.8 billion buyout of Prometheus Biosciences last year. In phase 2 results disclosed in ...

Teva Pharmaceuticals' shares soared and Sanofi's stock moved higher following positive results from the latest trial of their jointly developed treatment for inflammatory bowel disease. The ...

17 story has been corrected to say the results were for ulcerative colitis, not for both the diseases, in paragraph 5) Teva and Sanofi said last year they would collaborate on developing a ...